Neurology 1509 - Neurology Alert - Sep 01, 2011

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Claire Henchcliffe, MD, DPhil
Associate Professor of Neurology and Neuroscience;
Specialty area, Movement Disorders

Michael Rubin, MD, FRCP(C)

Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders

Dara Jamieson, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Authors

Jai S. Perumal, MD
Assistant Professor of Neurology
Weill Cornell Medical College

Melissa J. Nirenberg, MD, PhD
Assistant Professor, Neurology and Neuroscience
Weill Cornell Medical College

Subjects:

  • Can We Identify Pre-Motor Parkinson's Disease in LRRK2 Carriers?
  • Myopathic Side Effects from Statin Use
  • Does Higher Vitamin D Intake During Pregnancy Reduce the Risk of Multiple Sclerosis in Offspring?
  • Gabapentin Enacarbil for Sleep Disturbance in Restless Legs Syndrome
  • A Newly Described Motor Neuron Disease Mimic
  • Stroke Alert: A Review of Current Clinical Stroke Literature

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, reports no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study. Assistant editors Michael Rubin, MD, FRCP(C), Dara Jamieson, MD, author Melissa J. Nirenberg, MD, PhD, and peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study. Assistant editor Claire Henchcliffe, MD, DPhil reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmithKline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidpoint Global. Author Jai S. Perumal, MD is a consultant for Biogen Idec, and is on the speakers bureau for Teva and Biogen Idec.

Copyright 2011 AHC Media LLC. All rights reserved.